Supa Hannongbua

Dr. Supa Hannongbua

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
M. Paul GleesonM. Paul Gleeson
M. Paul Gleeson
AHAnne Hersey
Anne Hersey
SHSupa Hannongbua
Supa Hannongbua
ADME prediction is an extremely challenging area as many of the properties we try to predict are a result of multiple physiological processes. In this review we consider how in-silico predictions of ADME processes can be used to help bias medicinal chemistry into more ideal areas of property space, minimizing the number of compounds needed to be synthesized to obtain the required biochemical/physico-chemical profile. While such models are not sufficiently accurate to act as a replacement for in-vivo or in-vitro methods, in-silico methods nevertheless can help us to understand the underlying physico-chemical dependencies of the different ADME properties, and thus can give us inspiration on how to optimize them. Many global in-silico ADME models (i.e generated on large, diverse datasets) have been reported in the literature. In this paper we selectively review representatives from each distinct class and discuss their relative utility in drug discovery. For each ADME parameter, we limit our discussion to the most recent, most predictive or most insightful examples in the literature to highlight the current state of the art. In each case we briefly summarize the different types of models available for each parameter (i.e simple rules, physico-chemical and 3D based QSAR predictions), their overall accuracy and the underlying SAR. We also discuss the utility of the models as related to lead generation and optimization phases of discovery research.

1 March 2012 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
M. Paul GleesonM. Paul Gleeson
M. Paul Gleeson
SMSandeep Modi
Sandeep Modi
ABAndreas Bender
Andreas Bender
RRRichard L. Marchese Robinson
Richard L. Marchese Robinson
JKJohannes Kirchmair
Johannes Kirchmair
RGRobert C. Glen
Robert C. Glen
The percentage of failures in late pharmaceutical development due to toxicity has increased dramatically over the last decade or so, resulting in increased demand for new methods to rapidly and reliably predict the toxicity of compounds. In this review we discuss the challenges involved in both the building of in silico models on toxicology endpoints and their practical use in decision making. In particular, we will reflect upon the predictive strength of a number of different in silico models for a range of different endpoints, different approaches used to generate the models or rules, and limitations of the methods and the data used in model generation. Given that there exists no unique definition of a ‘good’ model, we will furthermore highlight the need to balance model complexity/interpretability with predictability, particularly in light of OECD/REACH guidelines. Special emphasis is put on the data and methods used to generate the in silico toxicology models, and their strengths and weaknesses are discussed. Switching to the applied side, we next review a number of toxicity endpoints, discussing the methods available to predict them and their general level of predictability (which very much depends on the endpoint considered). We conclude that, while in silico toxicology is a valuable tool to drug discovery scientists, much still needs to be done to, firstly, understand more completely the biological mechanisms for toxicity and, secondly, to generate more rapid in vitro models to screen compounds. With this biological understanding, and additional data available, our ability to generate more predictive in silico models should significantly improve in the future.

1 May 2005 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SCSantad Chanprapaph
Santad Chanprapaph
PSPatchreenart Saparpakorn
Patchreenart Saparpakorn
CSChak Sangma
Chak Sangma
PNPornwaratt Niyomrattanakit
Pornwaratt Niyomrattanakit
SHSupa Hannongbua
Supa Hannongbua
GKGerd Katzenmeier
Gerd Katzenmeier

21 October 2003 in Chemical Physics Letters
Verified
Journal Article
Closed access
MKMayuso Kuno
Mayuso Kuno
SHSupa Hannongbua
Supa Hannongbua
KMKeiji Morokuma
Keiji Morokuma

22 September 2009 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
WTWitcha Treesuwan
Witcha Treesuwan
KWKitiyaporn Wittayanarakul
Kitiyaporn Wittayanarakul
NANahoum G. Anthony
Nahoum G. Anthony
GHGuillaume Huchet
Guillaume Huchet
HAHasan Alniss
Hasan Alniss
SMSimon Paul Mackay
Simon Paul Mackay
In 2004, we used NMR to solve the structure of the minor groove binder thiazotropsin A bound in a 2 : 1 complex to the DNA duplex, d(CGACTAGTCG)2. In this current work, we have combined theory and experiment to confirm the binding thermodynamics of this system. Molecular dynamics simulations that use polarizable or non-polarizable force fields with single and separate trajectory approaches have been used to explore complexation at the molecular level. We have shown that the binding process invokes large conformational changes in both the receptor and ligand, which is reflected by large adaptation energies. This is compensated for by the net binding free energy, which is enthalpy driven and entropically opposed. Such a conformational change upon binding directly impacts on how the process must be simulated in order to yield accurate results. Our MM-PBSA binding calculations from snapshots obtained from MD simulations of the polarizable force field using separate trajectories yield an absolute binding free energy (−15.4 kcal mol−1) very close to that determined by isothermal titration calorimetry (−10.2 kcal mol−1). Analysis of the major energy components reveals that favorable non-bonded van der Waals and electrostatic interactions contribute predominantly to the enthalpy term, whilst the unfavorable entropy appears to be driven by stabilization of the complex and the associated loss of conformational freedom. Our results have led to a deeper understanding of the nature of side-by-side minor groove ligand binding, which has significant implications for structure-based ligand development.

3 April 2001 in Journal of Chemical Information and Computer Sciences
Verified
Journal Article
Closed access
SHSupa Hannongbua
Supa Hannongbua
KNKanda Nivesanond
Kanda Nivesanond
LLLuckhana Lawtrakul
Luckhana Lawtrakul
PPPornpan Pungpo
Pornpan Pungpo
PWPeter Wolschann
Peter Wolschann